Table 1:
A summary of various modes of action (MOAs) for rodent hepatocarcinogenicity and their corresponding gene alterations in rodent studies
Hepatotoxicity in 2-week Toxicology Study | |
---|---|
Hepatocarcinogenicity MOAs | Potential target genes |
Genotoxicity | Ccng1, Lama5, Cdkn1a, Mdm2, Nhej. |
Aryl hydrocarbon receptor (AhR) | Cyp1a1, Cyp1b1, Cyp1a2 |
Constitutive Androstane Receptor/Pregnane X Receptor (CAR/PXR) | Cyp2b1, Ces2c, Cyp3a23/3a1, Ugt2b1 |
Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) | Acot1, Cyp4a1, Ehhadh, Cpt1b, Vnn1 |
Estrogen Receptor | Rbp7, Cited4, Lifr, Orm1, Cyp4a8, Rgs3 |
Cytotoxicity | Anxa2, Gpnmb, Tubb6, S100a10, Trib3 |
Oxidative Stress/Nrf2 | Hmox1, Nqo1, Akr7a3, Srxn1, Gsta3 |
Inflammation | Lcn2, A2m, Lbp, Tnfrsf21, Cxcl9 |